Kestra Medical Technologies, Ltd.: net income or loss
Net income or loss for Kestra Medical Technologies, Ltd. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Kestra Medical Technologies, Ltd. financial histories
What this measure means
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
Exact concept: us-gaap:NetIncomeLoss. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2023-05-01 to 2026-04-30. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-05-01 | 2026-04-30 | -131,612,000 | USD | 2026-07-14 | 10-K · 0001193125-26-303397 |
| 2024-05-01 | 2025-04-30 | -113,814,000 | USD | 2026-07-14 | 10-K · 0001193125-26-303397 |
| 2023-05-01 | 2024-04-30 | -94,120,000 | USD | 2025-07-17 | 10-K · 0000950170-25-096609 |
Related financial histories
- Kestra Medical Technologies, Ltd.: total assets
- Kestra Medical Technologies, Ltd.: total liabilities
- Kestra Medical Technologies, Ltd.: cash and cash equivalents
- Kestra Medical Technologies, Ltd.: operating cash flow
- Kestra Medical Technologies, Ltd.: capital expenditure payments
- Kestra Medical Technologies, Ltd.: contract revenue excluding tax
- Kestra Medical Technologies, Ltd.: financing cash flow
- Kestra Medical Technologies, Ltd.: investing cash flow
- Kestra Medical Technologies, Ltd.: retained earnings or deficit
- Kestra Medical Technologies, Ltd.: basic weighted-average shares
- Kestra Medical Technologies, Ltd.: diluted weighted-average shares
- Kestra Medical Technologies, Ltd.: basic earnings per share
- Kestra Medical Technologies, Ltd.: diluted earnings per share
- Kestra Medical Technologies, Ltd.: income tax expense or benefit
- Kestra Medical Technologies, Ltd.: net property, plant and equipment
- Kestra Medical Technologies, Ltd.: share-based compensation expense
- Kestra Medical Technologies, Ltd.: operating income or loss
- Kestra Medical Technologies, Ltd.: current assets
- Kestra Medical Technologies, Ltd.: current liabilities
- Kestra Medical Technologies, Ltd.: current accounts payable
- Kestra Medical Technologies, Ltd.: operating expenses
- Kestra Medical Technologies, Ltd.: gross profit
- Kestra Medical Technologies, Ltd.: selling, general and administrative expense
- Kestra Medical Technologies, Ltd.: research and development expense
Inspect the source
- Entity
- Kestra Medical Technologies, Ltd. / CIK 0001877184
- Captured
- 2026-09-21T17:34:30.641Z
- SEC response SHA-256
349255c9a0b63038a49963b03c273268a4ab92a4aa83703220500dec893270fb
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001877184.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))